Congress and the Trump administration must work together to give Medicare the authority to negotiate drug prices with drugmakers to “protect American taxpayers,” an editorial states.
The editorial cites a recent case in Rockford, Illinois, where the city accused Mallinckrodt Pharmaceuticals of price gouging and Express Scripts of “failing to fairly negotiate drug prices.”
Rockford reportedly filed a suit against the companies after discovering it paid some $500,000 to treat to babies with infantile spasms.
“City authorities discovered they were paying about $40,000 a dose for medication that cost $40 in 2001,” the editorial states. “The city pays for health care for 1,000 employees and dependents.”